Immune Responses to Enzymes Replacement Therapies: Role of Immune Tolerance Induction
The FDA in co-sponsorship with the National Organization for Rare Disorders (NORD) is announcing a 1-day public workshop. The workshop will provide a forum to discuss the role of immune tolerance induction in patients receiving replacement biological products.
Date: June 9, 2014
Time: 8:00 am to 5:00 pm
Location: FDA White Oak Campus
Bldg. 31, Great Room 1503
Silver Spring, MD 20993
(Information about arrival to FDA’s White Oak campus)
There is no fee to attend the public workshop, but advanced online registration is recommended. Onsite registration is available on the day of the event but advanced registration is preferred. To register online, please visit https://events.rarediseases.org/?page_id=4&ee=13
The Workshop will also be available via webcast providing both audio and video broadcasting: https://collaboration.fda.gov/immuneresponse/.
Final agenda and slides available at the registration site: https://events.rarediseases.org/?ee=13
- Maureen Dewey
- Federal Register Notice